Your browser doesn't support javascript.
loading
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients.
Palich, R; Veyri, M; Marot, S; Vozy, A; Gligorov, J; Maingon, P; Marcelin, A-G; Spano, J-P.
Afiliação
  • Palich R; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Pitié Salpêtrière Hospital, Paris, France; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Hea
  • Veyri M; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Marot S; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Virology, Pitié Salpêtrière Hospital, Paris, France.
  • Vozy A; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Gligorov J; Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Maingon P; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Oncology Radiotherapy, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Marcelin AG; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Virology, Pitié Salpêtrière Hospital, Paris, France.
  • Spano JP; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
Ann Oncol ; 32(8): 1051-1053, 2021 08.
Article em En | MEDLINE | ID: mdl-33932501

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article